CHORDIA THERAPEUTICS INC (190A.T)

JPY 253.0

(1.2%)

EBITDA Summary of CHORDIA THERAPEUTICS INC

  • CHORDIA THERAPEUTICS INC's latest annual EBITDA in 2024 was -1.82 Billion JPY , down -934.76% from previous year.
  • CHORDIA THERAPEUTICS INC's latest quarterly EBITDA in 2024 Q4 was -648.05 Million JPY , down -67.64% from previous quarter.
  • CHORDIA THERAPEUTICS INC reported an annual EBITDA of 218.1 Million JPY in 2023, up 111.85% from previous year.
  • CHORDIA THERAPEUTICS INC reported an annual EBITDA of -1.77 Billion JPY in 2022, down -213.64% from previous year.
  • CHORDIA THERAPEUTICS INC reported a quarterly EBITDA of -370.17 Million JPY for 2024 Q3, down 0.0% from previous quarter.
  • CHORDIA THERAPEUTICS INC reported a quarterly EBITDA of N/A for 2023 FY, up 111.85% from previous quarter.

Annual EBITDA Chart of CHORDIA THERAPEUTICS INC (2024 - 2021)

Historical Annual EBITDA of CHORDIA THERAPEUTICS INC (2024 - 2021)

Year EBITDA EBITDA Growth
2024 -1.82 Billion JPY -934.76%
2023 218.1 Million JPY 111.85%
2022 -1.77 Billion JPY -213.64%
2021 -687.05 Million JPY 0.0%

Peer EBITDA Comparison of CHORDIA THERAPEUTICS INC

Name EBITDA EBITDA Difference